What the label lists and what reports show
Bacitracin and polymyxin b side effects
Bacitracin and polymyxin b's FDA label lists its adverse reactions in its own words. FAERS holds 109 reports naming it through July 30, 2026; the reaction reported most often, leaving out the conditions it is used for, product-use terms and outcomes, is weight increased (15 reports).
- Generic listed
Check it at the source: the bacitracin and polymyxin b FDA label on DailyMed (effective October 18, 2024, Bausch & Lomb Incorporated); the FDA FAERS public dashboard.
What does the label list?
From the label: adverse reactionsTo report SUSPECTED ADVERSE REACTIONS, contact Bausch & Lomb Incorporated at 1-800-553-5340 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Source: FDA drug label, Bausch & Lomb Incorporated, effective October 18, 2024 (SPL set 1b317249-30eb-4415-8a1c-cfedb4ba3549), via openFDA; the full label on DailyMed
What do FAERS reports show?
109 reports list bacitracin and polymyxin b among the medicines taken, each a report of something that happened, not proof the medicine caused it; 24 are coded as a death and 21 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is. Of the 23 reactions below, none is named by the same term (in US spelling) in the label's adverse reactions, warnings or patient leaflet; a reaction the label does not name may still be there under another word, and a report does not show that the medicine caused it.
The 25 most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; reactions as MedDRA preferred terms
What next?
- Bacitracin and polymyxin b: the full record
- label, generics, price, shortages, recalls
- Report a side effect to the FDA
- MedWatch
- Side effects hub
- the most reported medicines and reactions